Vaccine Scheduler
Germany: Recommended vaccinations
| General recommendation | |
| Recommendation for specific groups only | |
| Catch-up (e.g. if previous doses missed) | |
| Vaccination not funded by the National Health system | |
| Mandatory vaccination |
| Years | ||||||
|---|---|---|---|---|---|---|
| 18 | 24 | 59 | 60 | 65-74 | ≥ 75 | |
| RSV | RSV4 | RSV | ||||
| Coronavirus disease (COVID-19)1 | COVID-195 | COVID-195 | ||||
| diphtheria2 | d6 | |||||
| tetanus2 | TT6 | |||||
| pertussis2 | acp7 | |||||
| poliomyelitis2 | IPV8 | |||||
| pneumococcal disease2 | PCV20 | PCV20 | ||||
| meningococcal disease | MCV49 | |||||
| measles3 | MEAS10 | |||||
| influenza | IIV311 | aIIV3 / IIV3-HD 11 | ||||
| herpes zoster | ZOS12 | ZOS12 | ||||
Version:
Footnotes:
- https://www.rki.de/DE/Content/Infekt/Impfen/ImpfungenAZ/COVID-19/Impfempfehlung-Zusfassung.html
- Premature infants receive an additional vaccine dose at the age of 3 months; in total they receive 4 doses
- For more information on specific population groups where measles vaccination is mandatory please refer to https://www.masernschutz.de/themen/rechtliche-aspekte.html
- Vaccine offered only to persons with risk factors.
- Annual vaccination recommended for persons aged 60 years and older and for persons 6 months and older with increased health risk for a severe course of COVID-19 due to an underlying disease.
- Booster doses every 10 years, catch-up for those unvaccinated. The first due Td 10-yearly booster dose should be with a Tdacp vaccine. Subsequent booster doses are to be done with Td vaccines.
- The first due Td 10-yearly booster dose should be with a Tdacp vaccine. Subsequent booster doses are to be done with Td vaccines. Vaccination offered to pregnant women at the beginning of 3rd trimester. If there is an increased probability of premature birth, vaccination should be brought forward to the 2nd trimester. More information available at: RKI - Vaccinations A - Z - Scientific justification for recommending pertussis vaccination with a Tdap combination vaccine in pregnancy
- Catch-up for those unvaccinated
- For MenB, according to the product information, the vaccination series consists of 3 vaccine doses for children aged 2–23 months and 2 vaccine doses for children aged 24 months and older. For MenACWY, recommendation in October 2025 to vaccinate at age 12-14 (up until age 24) and recommendation against MenC vaccination for infants and small children
- One dose of measles for those aged 18 years and older and born after 1970 with no vaccination or uncertain vaccination history or only one vaccination during childhood
- Annual vaccination in autumn/winter with inactivated high-dose or MF-59 adjuvanted influenza vaccines recommended for persons aged 60 years and older. Annual vaccination with inactivated vaccine recommended for persons 6 months and older with one or more medical condition or underlying disease. Children and adolescents aged 2-17 years can be vaccinated with live attenuated vaccine.
- 2 doses with an interval of 2 to 6 months respectively between doses; for individuals aged 18-59 years only indicated for persons with certain medical condition or underlying disease associated with increased risk of herpes zoster. Vaccination with the inactivated herpes zoster subunit vaccine. See recommendation background paper: https://link.springer.com/article/10.1007/s00103-019-02882-5
More information available at:
https://www.rki.de/DE/Content/Kommissionen/STIKO/Empfehlungen/Impfempfehlungen_node.html
The German immunisation calendars in 16 foreign languages can be found here:
http://www.rki.de/DE/Content/Infekt/Impfen/Materialien/Impfkalender_mehrsprachig_Uebersicht_tab.html?nn=2709264
---------------------------------------------------------------------------------------
Recommendation for children with underlying medical conditions:
Vaccination recommendations for children with underlying medical conditions or specific health risks currently exist for the following diseases: Haemophilus influenzae type b, hepatitis A and B, influenza, meningococcal infections (groups A, C, W135, Y), and pneumococcal diseases. Specifics of those recommendations can be found in English at: www.stiko.de/en
---------------------------------------------------------------------------------------
January 2025: Introduction of the MenB vaccine.
---------------------------------------------------------------------------------------
Sept. 2023: Pneumococcal vaccination: recommendation change for adults. see for more details: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/39_23.pdf?__blob=publicationFile
---------------------------------------------------------------------------------------
01 March 2021: new measles mandatory vaccination requirements for specific population groups
https://www.masernschutz.de/themen/rechtliche-aspekte.html
---------------------------------------------------------------------------------------
22 August 2019: Launch of the 2019/2020 vaccination schedule
change include updated recommendation for Herpes-Zoster with an inactivated vaccine. see for more info: https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2018/Ausgaben/50_18.pdf%3F__blob%3DpublicationFile
---------------------------------------------------------------------------------------
31 August 2017: Publication of the 2017/2018 vaccination schedule
Changes include:
- A decision NOT to implement routine ZOSTER vaccination (immunisation is to be decided on a case-by-case basis)
- A revised policy for FLU vaccination of children aged 2-17 years
- For TETANUS post-exposure prophylaxis - ONLY recommended if a last dose was given more than 10 years ago. This applies to limited, clean wounds
- For HepA/HepB vaccination ; revision of the groups where vaccination is recommended
For more information, please refer to https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2017/Ausgaben/35_17.pdf?__blob=publicationFile
---------------------------------------------------------------------------------------
Date of last update: 11 February 2026